Bioavailability and newer methods of delivery of phosphorothioate radioprotectors

Brown, 1986, Modification of WR-2721 toxicity and radioprotection by an inhibitor of alkaline phosphatase, Int. J. Radiat. Oncol. Biol. Phys., 12, 1490, 10.1016/0360-3016(86)90201-4 Butler, 1985, Cystine depletion by WR-1065 in cystinotic cells, Biochem. Pharmac., 34, 2179, 10.1016/0006-2952(85)90415-0 Calabro-Jones, 1985, Alkaline phosphatase promotes radioprotection and accumulation of WR-1065 in V-79-171 cells incubated in medium containing WR-2721, Int. J. Radiat. Biol., 47, 23, 10.1080/09553008514550041 Conner, 1986, Bioavailability of the antiradiation compound ethiofos (WR-2721) in the rat, Pharm. Res., 3, 166S Davidson, 1980, Biological characteristics of some improved radioprotectors, 309 Davis, 1986, Transit of pharmaceutical dosage forms through the small intestine, Gut, 27, 886, 10.1136/gut.27.8.886 Dubois, 1986, Relation between gastric empyting and gastric motility in primates, Gastroenterology, 91, 1051A, 10.1016/0016-5085(86)90766-3 Fatome, 1987, Radioprotective activity of ethylcellulose microspheres containing WR-2721, after oral administration, Int. J. Radiat. Biol., 52, 21, 10.1080/09553008714551441 France, 1986, Intracolonic WR-2721 protection of the rat colon from acute radiation injury, Gastroenterology, 91, 644, 10.1016/0016-5085(86)90634-7 Mangold, 1986, Investigations concerning hydrolysis and stabilization of antiradiation compounds McGovern, 1984, HPLC assay for 2-(3-amino-propylamino)ethanethiol (WR-1065) in plasma, Int. J. Radiat. Oncol. Biol. Phys., 10, 1517, 10.1016/0360-3016(84)90493-0 Mori, 1984, Dephosphorylation of WR-2721 with mouse tissue homogenates, Int. J. Radiat. Oncol. Biol. Phys., 10, 1529, 10.1016/0360-3016(84)90496-6 Purdie, 1983, Interaction of cultured mammalian cells with WR-2721 and its thiol WR-1065: Implications for mechanisms of radioprotection, Int. J. Radiat. Biol., 43, 517, 10.1080/09553008314550611 Risley, 1986, Hydrolysis of S-2-(3-aminopropylamino)ethylphosphorothioiate (WR-2721), Biochem. Pharmac., 35, 1453, 10.1016/0006-2952(86)90109-7 Sarosiek, 1983, Retardation of hydrogen ion diffusion by gastric mucus constituents: Effect of proteolysis, Biochem. Biophys. Res. Commun., 115, 1053, 10.1016/S0006-291X(83)80042-4 Shaw, 1984, A liquid chromatographic electrochemical assay for S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721) in human plasma, J. Liq. Chromatogr., 7, 2447, 10.1080/01483918408068889 Shaw, 1986, Measurement of S-2-(3-aminopropylamino)ethanethiol (WR-1065) in blood and tissues, J. Liq. Chromatogr., 9, 845, 10.1080/01483918608076673 Stewart, 1986, Uptake of prodrugs by rat intestinal mucosal cells: Mechanism and pharmaceutical implications, J. Pharm. Sci., 75, 940, 10.1002/jps.2600751005 Sweeney, 1979 Swynnerton, 1983, HPLC assay for S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721) in plasma, J. Liq. Chromatogr., 6, 1523, 10.1080/01483918308064869 Swynnerton, 1984, An improved HPLC assay for S-2-(3-aminopropylamino)ethylphosphorothioate (WR-2721) in plasma, Int. J. Radiat. Oncol. Biol. Phys., 10, 1521, 10.1016/0360-3016(84)90494-2 Swynnerton, 1985, Measurement of ethiofos (WR-2721) in plasma: Preliminary pharmacokinetics in the beagle, J. Liq. Chromatogr., 8, 2675, 10.1080/01483918508076598 Swynnerton, 1986, A method for the combined measurement of ethiofos and WR-1065 in plasma: Application to pharmacokinetic experiments with ethiofos and its metabolites, Int. J. Radiat. Oncol. Biol. Phys., 12, 1495, 10.1016/0360-3016(86)90202-6 Swynnerton, 1986, Measurement of WR-1065 in plasma: Preliminary pharmacokinetics in the beagle, Res. Commun. Chem. Pathol. Pharmac., 54, 255 Tabachnik, 1982, Protein binding of N-2-mercaptoethyl-1,3-diaminopropane via mixed disulfide formation after oral administration of WR-2721, J. Pharmac. Exp. Ther., 220, 243